Site identity card

University Hospital Cologne

Cologne, Germany
Share

Networks

Clinical Studies (4)

  • HINT : Study aims to evaluate an app to improve communication and information flows for persons suffering from Post-COVID-19 syndrome
  • Orth : Study aims to analyse first-line COVID-19 combination regimens for virological and clinical outcomes and safety in a large cohort of immunocompromised patients
  • Mertens : Study aims to evaluate the cardiac, pulmonary, and liver function of patients who have had SARS-CoV-2 infection
  • BLOC : Study aims to investigate the efficacy, pharmacodynamics and safety of BC 007 in improving long COVID symptoms by neutralising functional autoantibodies targeting G-protein

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Hospital
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Monoclonal antibodies
  • Remdesivir
  • Nirmatrelvir/Ritonavir
  • Molnupiravir
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab
  • BC 007

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to